Kimberly M Murphy
CIK 1810474 · CEO and President · last filed 2024-09-20
Kimberly M Murphy is a CEO and President who has filed 9 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for OGEN, was dated Sep 20, 2024. Current disclosed insider exposure totals $15.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$15.5K
3
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OGEN | CEO and President | 25,000 | $0.62 | $15.5K | $0 | 6 | 2024-09-20 |
| Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Director | 5,766 | $0.01 | $78 | $0 | 2 | 2022-06-09 |
| Onconetix, Inc. (BWV) Delisted | Director | — | $0.18 | — | $0 | 1 | 2022-05-27 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-20 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2023-08-10 | OGEN | Grant (A) | +25,000 | $0 | EDGAR |
| 2022-06-24 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Grant (A) | +1,922 | $0 | EDGAR |
| 2022-05-27 | Onconetix, Inc. (BWV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-20 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2021-12-14 | Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Grant (A) | +3,844 | $0 | EDGAR |
| 2021-02-19 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2020-05-04 | OGEN | Grant (A) | — | $0 | EDGAR |